CXCL8 and acute kidney injury: Collectively, these findings indicate that IL-8 may function as an early warning biomarker for AKI and offer a theoretical and experimental framework for the formulation of novel therapeutic strategies targeting AKI (Fig. 2B and Fig. S4).